Clinical trial

Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

NCT01559116

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE3

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2015-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

tiotropium + olodaterolDRUG

tiotropiumDRUG · verified · RxNorm: tiotropium

olodaterolDRUG · verified · RxNorm: olodaterol

tiotropiumDRUG · verified · RxNorm: tiotropium

tiotropium + olodaterolDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

HamburgGermany2 BerlinGermany1 GreenvilleSouth Carolina, United States1 QuébecQuebec, Canada1 SpartanburgSouth Carolina, United States1 GhentBelgium1 SherbrookeQuebec, Canada1 MannheimGermany1 PécsHungary1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01559116 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.